Patented drug product international prices compared to prices in Canada 2004-2017

Average ratio of median international prices to Canadian prices for patented drugs from 2004 to 2017*

by Matej Mikulic, last edited Aug 29, 2018
Patented drug product international prices compared to prices in Canada 2004-2017 This statistic depicts the average ratio of median international prices to prices in Canada for patented drug products between 2004 to 2017. In 2007, the ratio between international prices and Canadian prices averaged 1.03. Drug prices in Canada have been on average lower than in other developed countries.
Show more

Average ratio of median international prices to Canadian prices for patented drugs from 2004 to 2017*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical market in Italy"
  • Market overview
The most important statistics
  • Pharmacy figures
  • Pharmaceutical expenditure
  • Pharmaceutical consumption
  • Brand name and generic drugs
  • Nonprescription drugs
  • Health supplements
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.